Perugino, C., Culver, E. L., Khosroshahi, A., Zhang, W., Della-Torre, E., Okazaki, K., . . . Stone, J. H. (2023). Efficacy and Safety of Inebilizumab in IgG4-Related Disease. Rheumatology and Therapy, 10(6), 1795. https://doi.org/10.1007/s40744-023-00593-7
Chicago-referens (17:e uppl.)Perugino, Cory, et al. "Efficacy and Safety of Inebilizumab in IgG4-Related Disease." Rheumatology and Therapy 10, no. 6 (2023): 1795. https://doi.org/10.1007/s40744-023-00593-7.
MLA-referens (9:e uppl.)Perugino, Cory, et al. "Efficacy and Safety of Inebilizumab in IgG4-Related Disease." Rheumatology and Therapy, vol. 10, no. 6, 2023, p. 1795, https://doi.org/10.1007/s40744-023-00593-7.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
